Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Alexion’s Ultra-Rare Kidney Disease Drug Passes Phase III With Flying Colors

Boston-based Alexion’s Ultomiris (ravulizumab-cwvz) hit the primary objective in a Phase III study of complement inhibitor-naïve patients with atypical hemolytic uremic syndrome.

Read More »

A Link Between Gum Disease and Alzheimer’s?

Researchers with Cortexyme published research in the journal Science Advances describing the role of Porphyromonas gingivalis, a bacteria that causes gingivitis, to Alzheimer’s disease.

Read More »

Clinical Trial Finds Formula in Merix Pharmaceutical’s RELEEV 1 Day Cold Sore Highly Active Against Herpes

Merix Pharmaceutical Corp. announced the company’s proprietary botanical extract formula VIRACEA was found to be highly active against HSV-1 and HSV-2 in laboratory testing.

Read More »

Yale Researchers Discover Immune System Protein That Can Help Suppress HIV

A new report released by researchers at Yale University could change the way some HIV patients are treated.

Read More »

A Blood Test That Can ID Alzheimer’s Risk Up To 16 Years Before Symptoms

Scientists at DZNE, HIH, and the University Hospital Tuebingen identified a protein in blood that can precisely track Alzheimer’s disease progression before the first symptoms appear.

Read More »

Chinese Government Takes Action Against CRISPR Researcher

China government officials told the Xinhua News Agency that the researcher who became world famous for using CRISPR on human embryos “will be transferred to public security authorities,” and the individuals involved in the research will be “severely dealt with according to the law.”

Read More »

Swiss team develop ‘microswimmer’ robot to deliver drugs through the body

The miniature robot – the bacteria-inspired brainchild of a team of scientists in Switzerland seeking new methods to deliver drugs to diseased tissue – is designed to wend its way through blood vessels and other systems in the body.

Read More »

Imbruvica fails to meet pancreatic cancer study goal

AbbVie Inc.’s blockbuster cancer treatment Imbruvica in combination with chemotherapy agents failed to meet the main goal in a late-stage study of patients with a form of pancreatic cancer.

Read More »

J&J and Apple Team up for AFib Program With Apple Watch

Janssen Pharmaceutical and Apple have teamed up to determine if a new app for the Apple Watch – which has a built-in electrocardiogram – can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead to stroke and other potentially devastating complications.

Read More »

Big Pharma poised for disruption in 2019 while mid-tier companies double down on innovation

JLL’s life sciences experts anticipate that Big Pharma during 2019 will adopt agile real estate strategies and more entrepreneurial approaches to reinvent R&D and compete with smaller enterprises that are doubling down on product innovation and delivery.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom